Catalyst Wire Dossier Catalyst Wire Dossier

Spartalizumab

spartalizumab · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Spartalizumab, covering 2021-10-25 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma [EARLY_Phase 1]

See pricing